FDA Reviewers Mixed Over Two New Cancer Drugs
99518
U.S. Food and Drug Administration  staff reviewers on Tuesday questioned clinical data for  non-Hodgkin's lymphoma drug Marqibo, made by Inex  Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc. .
455038
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol drug Vytorin after a study showed it was no better than a generic in preventing the build-up of fatty plaque.
704815
A new breast cancer drug is significantly better at preventing the spread and return of the disease than the current treatment, according to a new study in the Lancet medical journal.
304755
TORONTO - A standard treatment used to prevent the recurrence of breast cancer should be replaced by a newer drug, according to a study released Wednesday.
719897
The move appeared to be a competitive strategy and based on public concerns about the costs of new cancer drugs.
424340
A small study shows its cancer treatment is comparable to others in terms of usefulness. Safety data is unknown.
703630
U.S. Food and Drug Administration staff reviewers on Tuesday questioned clinical data for non-Hodgkin's lymphoma drug Marqibo, made by Inex Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc..
57060
WASHINGTON -- Women with an aggressive form of advanced breast cancer that other treatments have failed to stop gained a new option yesterday with the approval of a novel drug -- but how much benefit it offers is unclear.
586343
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with anemia drugs sold by Amgen Inc  and Johnson & Johnson .
336236
U.S. regulators said on Friday they would review a study showing a Merck and Schering-Plough cholesterol drug worked no better than a generic in preventing the build-up of arterial plaque.
232184
Women diagnosed with breast cancer should be given a new drug instead of the standard treatment because it is safer, more effective and may increase overall survival rates, doctors have suggested.
421686
Five years ago, Portland&#39;s Dr. Brian Druker told a gathering of blood scientists about a few dozen cancer patients who were taking an obscure new drug with surprising success.
238158
Health care advocates, providers and FDA officials over the weekend &#39;sparred&#39; over alleged problems with the FDA prescription drug safety review process and the safety of five medications currently on the market, after an FDA safety reviewer on Thursday
582657
New reports suggest another drug company moved too slowly to pull a dangerous medication from the market and question the Food and Drug Administration&#39;s ability to protect the public.
737440
An unsurprising response from the FDA.
576330
Local researchers have found that two new designer drugs produce strong responses in patients who&#39;ve become resistant to Gleevec, the leukemia wonder drug that heralded a new era in cancer treatment 3 1/2 years ago.
228850
Older women with early breast cancer should take a new drug to cut the chance of the disease returning and spreading, it is claimed.